Chelsea Johnson
Principal at Atlas Venture
Greater Boston
Overview
Work Experience
Principal
2021 - Current
Building and investing in therapeutics companies advancing potentially transformative new medicines for patients. Co-founder and board member or observer for multiple emerging biotechs.
Senior Associate
2019 - 2021
Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, we have been building breakthrough biotech startups since 1993. We work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Our seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value. For more information, please visit www.atlasventure.com.
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Associate Director Business Development and Strategy
2017 - 2019
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Raised $351,000,000.00 from Casdin Capital, RA Capital Management, Woodline Partners, Boxer Capital, EcoR1 Capital, Surveyor Capital, Farallon Capital Management, Avoro Capital Advisors, Gilead Sciences and Samsara BioCapital.
Senior Associate
2016 - 2017
Associate
2015 - 2016
Graduate Student Researcher
2010 - 2015
Dissertation topic: Genomic and Functional Studies of Uveal Melanoma
Undergraduate Student Researcher
2007 - 2010
Senior Honors Thesis Title: "Id4 is required for adipocyte differentiation"
Oncology Intern
2009 - 2009